Biomarkers Seen in Patients’ Blood Show Potential IPF Disease

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email


Findings by a team of researchers suggest that levels of circulating endothelial cells and fibrocytes may be used as predictive biomarkers in idiopathic pulmonary fibrosis (IPF). The team’s study, “Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments,” was published in the journal BMC Medicine.


Read more about this here: